At close: December 11 at 4:00:00 PM EST
Pre-Market: 5:04:18 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 4 | 6 | 6 |
| Avg. Estimate | -0.02 | -0 | -0.12 | 0.2 |
| Low Estimate | -0.18 | -0.15 | -0.29 | -0.31 |
| High Estimate | 0.14 | 0.06 | 0.07 | 0.54 |
| Year Ago EPS | -0.13 | -0.12 | -0.9 | -0.12 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 5 | 10 | 10 |
| Avg. Estimate | 40.39M | 40.73M | 140.08M | 187.99M |
| Low Estimate | 40M | 39.7M | 139.46M | 179.7M |
| High Estimate | 41.13M | 43.3M | 140.85M | 199.94M |
| Year Ago Sales | 28.58M | 29.51M | 89.08M | 140.08M |
| Sales Growth (year/est) | 41.31% | 38.02% | 57.25% | 34.21% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.27 | -0.19 | -0.11 | -0.07 |
| EPS Actual | -0.13 | -0.12 | 0 | 0 |
| Difference | 0.14 | 0.07 | 0.11 | 0.07 |
| Surprise % | 52.29% | 36.44% | 100.64% | 100.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.02 | -0 | -0.12 | 0.2 |
| 7 Days Ago | 0.01 | -0.01 | -0.09 | 0.21 |
| 30 Days Ago | -0.01 | -0.05 | -0.2 | 0.18 |
| 60 Days Ago | -0.01 | -0.05 | -0.2 | 0.18 |
| 90 Days Ago | -0.01 | -0.05 | -0.2 | 0.18 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 3 | 2 |
| Up Last 30 Days | 2 | 2 | 4 | 4 |
| Down Last 7 Days | 2 | -- | -- | 1 |
| Down Last 30 Days | 2 | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RXST | 88.09% | 98.04% | 87.12% | 271.99% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 12/11/2024 |
| Initiated | UBS: Buy | 12/6/2024 |
| Initiated | Jefferies: Buy | 10/29/2024 |
| Reiterates | Needham: Buy to Buy | 9/13/2024 |
| Maintains | Needham: Buy to Buy | 8/20/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 8/6/2024 |
Related Tickers
SGHT Sight Sciences, Inc.
3.9000
-0.26%
GKOS Glaukos Corporation
142.89
+4.77%
NARI Inari Medical, Inc.
58.21
+5.74%
PRCT PROCEPT BioRobotics Corporation
90.61
-0.61%
LNSR LENSAR, Inc.
7.64
+0.92%
INSP Inspire Medical Systems, Inc.
192.77
+1.77%
OFIX Orthofix Medical Inc.
18.54
-0.05%
RPID Rapid Micro Biosystems, Inc.
1.0100
-2.88%
UFPT UFP Technologies, Inc.
295.60
+1.68%
OM Outset Medical, Inc.
1.2300
-4.65%